Okay is a digital security company, providing PSD2 SCA-compliant security solutions. At Okay we take a paranoid approach to security, and through unique security mechanisms, we are able to offer a unique SCA solution. The journey of the Okay solution started out within Protectoria AS as early as 2014, and it was a response to the increased focus on security within the banking industry. The product has kept on evolving and growing, and Okay was finally separated out as a company in early 2020.

Octo Ventures, based in Oslo, Norway, is an incubator that initiates, invests in, and develops companies together with external co-founders. Based on investment criteria that have proved to deliver superior returns, we have developed a proprietary algorithm that generates high-potential ideas. Our methodology combines best practices within innovation, product development, and business design to accelerate the process from concept development to MVP and commercial launch.

Propely er et ungt og nytenkende tech-selskap som leverer revolusjonerende programvare til eiendomsbransjen. Vi skiller oss ut ved å levere en sømløs plattform for kommunikasjon mellom utleiere, leietakere og leverandører, en plattform som gir en bedre og mer effektiv drift av eiendommer, samt mer fornøyde brukere av byggene.

Betongsentrum AS is offering an easier online solution for planning and ordering concrete for your project. Our digital platform makes concrete deliveries more efficient, safer and more environmentally friendly along with giving all project participants a visual overview of the progress and their own responsibilities. This ensures quality in every link, satisfied customers and a better end result.

UNISOT is a young Norwegian start-up company and is the first global Blockchain solution based on tight integration with Enterprise Resource Planning (ERP) systems, such as SAP and other major ERP and SCM systems. Its permissionless manner will allow unprecedented abilities for secure information exchange and secure information storage to companies and/or organizations all over the world. For the first time and with the help of the open, public blockchain, UNISOT can now offer access to a reliable and secure “Universal Source of Truth” that all parties can use to handle the challenges in today’s supply chain environment, such as increased globalization, faster pace of change, global traceability, information shortage, and settlement costs, to name a few. UNISOT is leveraging the very well-established ERP Business Processes with the trust, security, immutability, and tokenization that the Open Public Permissionless Blockchain technology provides.

Alfa Audio Solutions AS is a competitive service-oriented company with long and solid experience in audiovisual solutions. With over 30 years of work in this field, we offer smart, user-friendly and reliable AV solutions, focusing on customer needs and wishes. Our services are aimed at businesses, businesses and the private market. We offer everything from simple installations to complex meeting room solutions. Video conferencing systems with Skype for Business, information screens and digital signage for your advertising message. Interactive tables for teaching and classrooms.

Ose Water AS is a Norwegian bottled water and bag-in-box water producer.The water source is Ose which provides high quality natural mineral water. The company aim to be in production for international sale in Q1 2019. Ose Water AS is a producer of natural mineral water from the Ose spring in Bygland municipality, Aust-Agder county in Norway.

High-quality cargo bikes and high-tech solutions for urban mobility. Bogbi is a  Norwegian-Colombian startup that produces cargo bikes in Bogota for the national and international markets with a strong integrated social impact. Our bikes are handmade by Norwegian industrial designer Johannes Hegdahl and Colombian engineer David Duarte, as well as excellent welders and other local providers of components and engineering here in Bogota. In all moderation, we are being told that we have developed a world-class product. At Bogbi we want our bikes to contribute to Colombia's future in peace. Together with the Norwegian Refugee Council, and the Colombian company Mejor en Bici we are setting up a pilot -project to provide vocational training for young people involved in the conflict to become welders, entrepreneurs and eventually work with us to develop what we call: bike magic from Colombia. To increase our impact on society and the environment we have teamed up with the Norwegian organization International Development Norway and Innovation Norway. Together we will develop a digital platform for last-mile delivery service. This will enable companies to bring goods from business to business using cargo bikes and create employment for vulnerable groups, as well. We were accepted to apply for Innovation Norway's vision 2030 grants to develop a last-mile delivery service in Bogota and around the world. The grant is for three years to develop software and bikes to establish a b2b pilot here in Bogota with international We are located in Bogota with our own production facility and capacity to produce up to 40 bikes per month.

Monio AS (org. nr. 913 978 617) er et heleid datterselskap av SpareBank 1 SR-Bank ASA (org. nr. 937 895 321). Monio AS formidler lån til små og mellomstore bedrifter og er regulert av Finanstilsynet med tillatelse til å drive virksomhet som betalingsforetak og er registrert som låneformidler. Som lånformidler er Monio ikke en part i låneavtalen mellom långiver og låntaker.

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Hvem er vi ? TICOM har en liten, men sammensveiset kjerne med bakgrunn innenfor innovativ mobilteknologi, og som de senere årene har jobbet med å utvikle lignende høykvalitetsprodukter innenfor klokker og headsets. Det er også gjennom denne kunnskapen og erfaringen våre medlemmer har opparbeidet seg et unikt kontaktnettverk I Asia, noe som igjen gjør at TICOM har tilgang til kvalitetsprodukter til priser få kan konkurrere med I vesten. Hvis noen I det hele tatt. Vi har egne og lokale representanter “på bakken” I Kina og Thailand. Samtidig har vi tilknyttet vårt nettverk en ny ressurs innen PR, Medier og samfunnskontakt som har lang internasjonal erfaring på høyt plan, blant annet I FN hvor han begynte I WHO I 1993.

Gruten is an Oslo-based company that creates new value and meaning from coffee waste. We use coffee grounds in the production of soap and body scrub, and run an educational program with lectures, courses, and workshops to create awareness and knowledge about coffee grounds as a valuable resource.  We have a small production/workshop/outlet at Torshov, and sell our products on our own webshop + in ca 35 stores around Oslo and the rest of Norway. At the moment we are working hard to set up a site for mushroom production, growing oyster mushrooms on coffee grounds. When we get a go-ahead for this we will be in demand for funding to set up the production site (we will be growing in used cooling containers, so-called reefers) and need people to work on the site.

Our ambition is to offer a product that protects against virus infections in the upper airways, and helps to maintain a healthy nose Keeping the mucous membranes moist is by many ENT-doctors seen as one of the most important measures you can take to prevent viruses from entering through the nasal mucosa, and in general maintaining a healthy nose.

We turn life science and deep tech ideas into commercially successful companies. We serve both as a consultancy and as a venture builder. At Marigold Innovation, we build bridges between research and business, science and product, researchers and investors. Most scientists prefer to stay where they add the most value, namely as highly skilled scientists and inventors who understand the translational process at an intellectual level, without the deep insight and experience in how to execute accordingly. ​We want to ensure that the skilled scientists focus on what they excel in – doing science and inventing stuff! ​ Marigold Innovation closes the gap by bringing the competences required to complement the scientific team. In this way we ensure that all necessary skills are in place at the needed timepoint and at the right level to secure the optimal development path from academia to a commercially viable company.